Follow
Aysegul Erman
Title
Cited by
Cited by
Year
Rab18 and Rab43 have key roles in ER-Golgi trafficking
SY Dejgaard, A Murshid, A Erman, O Kızılay, D Verbich, R Lodge, ...
Journal of cell science 121 (16), 2768-2781, 2008
1832008
Estimating chronic hepatitis C prognosis using transient elastography‐based liver stiffness: a systematic review and meta‐analysis
A Erman, A Sathya, A Nam, JM Bielecki, JJ Feld, HH Thein, WWL Wong, ...
Journal of viral hepatitis 25 (5), 502-513, 2018
472018
Human growth hormone receptor (GHR) expression in obesity: I. GHR mRNA expression in omental and subcutaneous adipose tissues of obese women
A Erman, A Veilleux, A Tchernof, CG Goodyer
International journal of obesity 35 (12), 1511-1519, 2011
402011
Estimation of fibrosis progression rates for chronic hepatitis C: a systematic review and meta-analysis update
A Erman, MD Krahn, T Hansen, J Wong, JM Bielecki, JJ Feld, WWL Wong, ...
BMJ open 9 (11), e027491, 2019
392019
Exploring the effect of collective cultural attributes on Covid-19-related public health outcomes
A Erman, M Medeiros
Frontiers in psychology 12, 627669, 2021
38*2021
Antiviral treatment for treatment-na´ve chronic hepatitis B: systematic review and network meta-analysis of randomized controlled trials
WWL Wong, P Pechivanoglou, J Wong, JM Bielecki, A Haines, A Erman, ...
Systematic Reviews 8, 1-15, 2019
332019
Model-based projection of health and economic effects of screening for hepatitis C in Canada
WWL Wong, A Erman, JJ Feld, M Krahn
Canadian Medical Association Open Access Journal 5 (3), E662-E672, 2017
322017
Human growth hormone receptor (GHR) expression in obesity: II. Regulation of the human GHR gene by obesity-related factors
A Erman, M Wabitsch, CG Goodyer
International journal of obesity 35 (12), 1520-1529, 2011
292011
Pharmacotherapy vs surgery as initial therapy for patients with moderate‐to‐severe benign prostate hyperplasia: a cost‐effectiveness analysis
A Erman, L Masucci, MD Krahn, DS Elterman
BJU international 122 (5), 879-888, 2018
242018
A vaccination strategy for Ontario COVID-19 hotspots and essential workers
S Mishra, NM Stall, H Ma, A Odutayo, JC Kwong, U Allen, KA Brown, ...
Science Briefs of the Ontario COVID-19 Science Advisory Table 2 (26), 10.47326, 2021
212021
Cost analysis of Greenlight photoselective vaporization of the prostate compared to transurethral resection of the prostate for benign prostatic hyperplasia
L Masucci, A Erman, MD Krahn, D Elterman
Canadian Urological Association Journal 12 (12), 382, 2018
212018
Pharmacotherapy vs. minimally invasive therapies as initial therapy for moderate-to-severe benign prostatic hyperplasia: a cost-effectiveness study
Y Sahakyan, A Erman, N Bhojani, B Chughtai, KC Zorn, B Sander, ...
Prostate Cancer and Prostatic Diseases 26 (1), 113-118, 2023
162023
Cost-effectiveness analysis of extended adjuvant endocrine therapy in the treatment of post-menopausal women with hormone receptor positive breast cancer
A Erman, A Nugent, E Amir, PC Coyte
Breast cancer research and treatment 145, 267-279, 2014
122014
The health impact of delaying direct‐acting antiviral treatment for chronic hepatitis C: A decision‐analytic approach
A Erman, WWL Wong, JJ Feld, P Grootendorst, MD Krahn
Liver International 50 (1), 51-59, 2020
82020
Engagement with the HCV care cascade among high-risk groups: a population-based study
A Erman, K Everett, WWL Wong, F Forouzannia, C Greenaway, N Janjua, ...
Hepatology Communications 7 (9), e0222, 2023
42023
Personality traits of world leaders and differential policy responses to the COVID-19 pandemic
M Medeiros, A Nai, A Erman, E Young
Social Science & Medicine 311, 115358, 2022
4*2022
The 8th Canadian Symposium on Hepatitis C virus: “Improving diagnosis and linkage to care”
SE Cousineau, A Erman, L Liu, S Saeed, L Fradette, JJ Feld, J Grebely, ...
Canadian Liver Journal 3 (1), 3-14, 2020
42020
Cost-utility of minimally invasive therapies vs. pharmacotherapy as initial therapy for benign prostatic hyperplasia: a Canadian healthcare payer perspective
Y Sahakyan, A Erman, N Bhojani, B Chughtai, KC Zorn, B Sander, ...
Canadian Urological Association Journal 17 (4), 103, 2023
22023
Impact of COVID-19 on scheduled lower extremity revascularization for chronic limb-threatening ischemia
A Erman, LC Ramsay, B Sander, W Haj-Ali, D Wu, M Setterfield, M Rahal, ...
British Journal of Surgery 109 (1), e5-e7, 2022
22022
Economic Evaluations to inform resource allocation for the prevention and management of Clostridioides difficile infections: A scoping review protocol
M Richardson, A Erman, B Sander
OSF, 2020
22020
The system can't perform the operation now. Try again later.
Articles 1–20